The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Blood Banking and Blood Products Market Research Report 2025

Global Blood Banking and Blood Products Market Research Report 2025

Publishing Date : Apr, 2025

License Type :
 

Report Code : 1705404

No of Pages : 113

Ask Your Query
Synopsis
The global market for Blood Banking and Blood Products was valued at US$ 57320 million in the year 2024 and is projected to reach a revised size of US$ 91740 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Blood banking is the process that takes place in the lab to make sure that donated blood, or blood products, are safe before they are used in blood transfusions and other medical procedures. Blood banking includes typing the blood for transfusion and testing for infectious diseases. A blood product is any therapeutic substance prepared from human blood. This includes: whole blood; blood components; and plasma derivatives. Whole blood is not commonly used in transfusion medicine.
Blood products refer to various human plasma protein products, including albumin, immunoglobulin, coagulation factors, etc. The raw material of blood products is plasma. 92% - 93% of human plasma is water, and only 7% - 8% is protein. Blood products are made by separating and purifying this part of protein.
The primary driver of the blood banking market is the increasing prevalence of chronic diseases and the rising number of surgical procedures globally. Conditions such as cancer, anemia, and trauma often require blood transfusions, boosting the demand for blood and blood products. Additionally, advancements in medical technology, such as improved blood preservation techniques and the development of blood substitutes, have enhanced the efficiency of blood banking systems, further contributing to market growth. One major challenge in the blood banking market is the risk of blood contamination and the transmission of infectious diseases. Despite stringent screening processes, there remains a possibility of contamination, especially in regions with less advanced healthcare systems. Furthermore, the high cost of blood testing and the maintenance of blood banks, coupled with the difficulty in ensuring a consistent blood supply due to low donation rates in some areas, presents significant obstacles to market expansion.
The growing prevalence of immunodeficiency disorders, hemophilia, and other chronic diseases that require plasma-derived therapies is a key driver of the blood product market. Blood products, such as immunoglobulins, clotting factors, and albumin, are essential in treating conditions where patients have compromised immune systems or bleeding disorders. Furthermore, the increasing use of plasma products in emergency care and surgical procedures, along with advancements in fractionation technologies, is boosting market demand. A major challenge in the blood product market is the high cost and complexity of the plasma collection and fractionation process. The production of blood products requires strict regulatory compliance and advanced facilities to ensure the purity and safety of these therapies, driving up costs. Additionally, fluctuations in plasma donation rates and the need for extensive screening to prevent contamination or the spread of infectious diseases can lead to supply shortages, especially in regions with underdeveloped healthcare infrastructure.
This report aims to provide a comprehensive presentation of the global market for Blood Banking and Blood Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Banking and Blood Products.
The Blood Banking and Blood Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Banking and Blood Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Banking and Blood Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
America’s Blood Centers
Japan Red Cross Society
American Red Cross
Australia Red Cross
Red Cross Society of China
NHS Blood and Transplant
New York Blood Center
Canadian Blood Services
Sanquin Blood Supply Foundation
Blood Bank of Alaska
Vitalant
National Blood Transfusion Council
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Segment by Type
RBCs
Plts
Plasma
Whole Blood
Plasma Fractionation Products
Segment by Application
Hospital
Clinic
Retail Pharmacy
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Banking and Blood Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Banking and Blood Products Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 RBCs
1.2.3 Plts
1.2.4 Plasma
1.2.5 Whole Blood
1.2.6 Plasma Fractionation Products
1.3 Market by Application
1.3.1 Global Blood Banking and Blood Products Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Retail Pharmacy
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Banking and Blood Products Market Perspective (2020-2031)
2.2 Global Blood Banking and Blood Products Growth Trends by Region
2.2.1 Global Blood Banking and Blood Products Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Blood Banking and Blood Products Historic Market Size by Region (2020-2025)
2.2.3 Blood Banking and Blood Products Forecasted Market Size by Region (2026-2031)
2.3 Blood Banking and Blood Products Market Dynamics
2.3.1 Blood Banking and Blood Products Industry Trends
2.3.2 Blood Banking and Blood Products Market Drivers
2.3.3 Blood Banking and Blood Products Market Challenges
2.3.4 Blood Banking and Blood Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Banking and Blood Products Players by Revenue
3.1.1 Global Top Blood Banking and Blood Products Players by Revenue (2020-2025)
3.1.2 Global Blood Banking and Blood Products Revenue Market Share by Players (2020-2025)
3.2 Global Blood Banking and Blood Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Blood Banking and Blood Products Revenue
3.4 Global Blood Banking and Blood Products Market Concentration Ratio
3.4.1 Global Blood Banking and Blood Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Banking and Blood Products Revenue in 2024
3.5 Global Key Players of Blood Banking and Blood Products Head office and Area Served
3.6 Global Key Players of Blood Banking and Blood Products, Product and Application
3.7 Global Key Players of Blood Banking and Blood Products, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Banking and Blood Products Breakdown Data by Type
4.1 Global Blood Banking and Blood Products Historic Market Size by Type (2020-2025)
4.2 Global Blood Banking and Blood Products Forecasted Market Size by Type (2026-2031)
5 Blood Banking and Blood Products Breakdown Data by Application
5.1 Global Blood Banking and Blood Products Historic Market Size by Application (2020-2025)
5.2 Global Blood Banking and Blood Products Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Blood Banking and Blood Products Market Size (2020-2031)
6.2 North America Blood Banking and Blood Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Blood Banking and Blood Products Market Size by Country (2020-2025)
6.4 North America Blood Banking and Blood Products Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Banking and Blood Products Market Size (2020-2031)
7.2 Europe Blood Banking and Blood Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Blood Banking and Blood Products Market Size by Country (2020-2025)
7.4 Europe Blood Banking and Blood Products Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Banking and Blood Products Market Size (2020-2031)
8.2 Asia-Pacific Blood Banking and Blood Products Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Blood Banking and Blood Products Market Size by Region (2020-2025)
8.4 Asia-Pacific Blood Banking and Blood Products Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Banking and Blood Products Market Size (2020-2031)
9.2 Latin America Blood Banking and Blood Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Blood Banking and Blood Products Market Size by Country (2020-2025)
9.4 Latin America Blood Banking and Blood Products Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Banking and Blood Products Market Size (2020-2031)
10.2 Middle East & Africa Blood Banking and Blood Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Blood Banking and Blood Products Market Size by Country (2020-2025)
10.4 Middle East & Africa Blood Banking and Blood Products Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 America’s Blood Centers
11.1.1 America’s Blood Centers Company Details
11.1.2 America’s Blood Centers Business Overview
11.1.3 America’s Blood Centers Blood Banking and Blood Products Introduction
11.1.4 America’s Blood Centers Revenue in Blood Banking and Blood Products Business (2020-2025)
11.1.5 America’s Blood Centers Recent Development
11.2 Japan Red Cross Society
11.2.1 Japan Red Cross Society Company Details
11.2.2 Japan Red Cross Society Business Overview
11.2.3 Japan Red Cross Society Blood Banking and Blood Products Introduction
11.2.4 Japan Red Cross Society Revenue in Blood Banking and Blood Products Business (2020-2025)
11.2.5 Japan Red Cross Society Recent Development
11.3 American Red Cross
11.3.1 American Red Cross Company Details
11.3.2 American Red Cross Business Overview
11.3.3 American Red Cross Blood Banking and Blood Products Introduction
11.3.4 American Red Cross Revenue in Blood Banking and Blood Products Business (2020-2025)
11.3.5 American Red Cross Recent Development
11.4 Australia Red Cross
11.4.1 Australia Red Cross Company Details
11.4.2 Australia Red Cross Business Overview
11.4.3 Australia Red Cross Blood Banking and Blood Products Introduction
11.4.4 Australia Red Cross Revenue in Blood Banking and Blood Products Business (2020-2025)
11.4.5 Australia Red Cross Recent Development
11.5 Red Cross Society of China
11.5.1 Red Cross Society of China Company Details
11.5.2 Red Cross Society of China Business Overview
11.5.3 Red Cross Society of China Blood Banking and Blood Products Introduction
11.5.4 Red Cross Society of China Revenue in Blood Banking and Blood Products Business (2020-2025)
11.5.5 Red Cross Society of China Recent Development
11.6 NHS Blood and Transplant
11.6.1 NHS Blood and Transplant Company Details
11.6.2 NHS Blood and Transplant Business Overview
11.6.3 NHS Blood and Transplant Blood Banking and Blood Products Introduction
11.6.4 NHS Blood and Transplant Revenue in Blood Banking and Blood Products Business (2020-2025)
11.6.5 NHS Blood and Transplant Recent Development
11.7 New York Blood Center
11.7.1 New York Blood Center Company Details
11.7.2 New York Blood Center Business Overview
11.7.3 New York Blood Center Blood Banking and Blood Products Introduction
11.7.4 New York Blood Center Revenue in Blood Banking and Blood Products Business (2020-2025)
11.7.5 New York Blood Center Recent Development
11.8 Canadian Blood Services
11.8.1 Canadian Blood Services Company Details
11.8.2 Canadian Blood Services Business Overview
11.8.3 Canadian Blood Services Blood Banking and Blood Products Introduction
11.8.4 Canadian Blood Services Revenue in Blood Banking and Blood Products Business (2020-2025)
11.8.5 Canadian Blood Services Recent Development
11.9 Sanquin Blood Supply Foundation
11.9.1 Sanquin Blood Supply Foundation Company Details
11.9.2 Sanquin Blood Supply Foundation Business Overview
11.9.3 Sanquin Blood Supply Foundation Blood Banking and Blood Products Introduction
11.9.4 Sanquin Blood Supply Foundation Revenue in Blood Banking and Blood Products Business (2020-2025)
11.9.5 Sanquin Blood Supply Foundation Recent Development
11.10 Blood Bank of Alaska
11.10.1 Blood Bank of Alaska Company Details
11.10.2 Blood Bank of Alaska Business Overview
11.10.3 Blood Bank of Alaska Blood Banking and Blood Products Introduction
11.10.4 Blood Bank of Alaska Revenue in Blood Banking and Blood Products Business (2020-2025)
11.10.5 Blood Bank of Alaska Recent Development
11.11 Vitalant
11.11.1 Vitalant Company Details
11.11.2 Vitalant Business Overview
11.11.3 Vitalant Blood Banking and Blood Products Introduction
11.11.4 Vitalant Revenue in Blood Banking and Blood Products Business (2020-2025)
11.11.5 Vitalant Recent Development
11.12 National Blood Transfusion Council
11.12.1 National Blood Transfusion Council Company Details
11.12.2 National Blood Transfusion Council Business Overview
11.12.3 National Blood Transfusion Council Blood Banking and Blood Products Introduction
11.12.4 National Blood Transfusion Council Revenue in Blood Banking and Blood Products Business (2020-2025)
11.12.5 National Blood Transfusion Council Recent Development
11.13 Takeda
11.13.1 Takeda Company Details
11.13.2 Takeda Business Overview
11.13.3 Takeda Blood Banking and Blood Products Introduction
11.13.4 Takeda Revenue in Blood Banking and Blood Products Business (2020-2025)
11.13.5 Takeda Recent Development
11.14 CSL
11.14.1 CSL Company Details
11.14.2 CSL Business Overview
11.14.3 CSL Blood Banking and Blood Products Introduction
11.14.4 CSL Revenue in Blood Banking and Blood Products Business (2020-2025)
11.14.5 CSL Recent Development
11.15 Grifols
11.15.1 Grifols Company Details
11.15.2 Grifols Business Overview
11.15.3 Grifols Blood Banking and Blood Products Introduction
11.15.4 Grifols Revenue in Blood Banking and Blood Products Business (2020-2025)
11.15.5 Grifols Recent Development
11.16 Octapharma
11.16.1 Octapharma Company Details
11.16.2 Octapharma Business Overview
11.16.3 Octapharma Blood Banking and Blood Products Introduction
11.16.4 Octapharma Revenue in Blood Banking and Blood Products Business (2020-2025)
11.16.5 Octapharma Recent Development
11.17 Kedrion
11.17.1 Kedrion Company Details
11.17.2 Kedrion Business Overview
11.17.3 Kedrion Blood Banking and Blood Products Introduction
11.17.4 Kedrion Revenue in Blood Banking and Blood Products Business (2020-2025)
11.17.5 Kedrion Recent Development
11.18 LFB Group
11.18.1 LFB Group Company Details
11.18.2 LFB Group Business Overview
11.18.3 LFB Group Blood Banking and Blood Products Introduction
11.18.4 LFB Group Revenue in Blood Banking and Blood Products Business (2020-2025)
11.18.5 LFB Group Recent Development
11.19 Biotest
11.19.1 Biotest Company Details
11.19.2 Biotest Business Overview
11.19.3 Biotest Blood Banking and Blood Products Introduction
11.19.4 Biotest Revenue in Blood Banking and Blood Products Business (2020-2025)
11.19.5 Biotest Recent Development
11.20 BPL
11.20.1 BPL Company Details
11.20.2 BPL Business Overview
11.20.3 BPL Blood Banking and Blood Products Introduction
11.20.4 BPL Revenue in Blood Banking and Blood Products Business (2020-2025)
11.20.5 BPL Recent Development
11.21 RAAS
11.21.1 RAAS Company Details
11.21.2 RAAS Business Overview
11.21.3 RAAS Blood Banking and Blood Products Introduction
11.21.4 RAAS Revenue in Blood Banking and Blood Products Business (2020-2025)
11.21.5 RAAS Recent Development
11.22 CBPO
11.22.1 CBPO Company Details
11.22.2 CBPO Business Overview
11.22.3 CBPO Blood Banking and Blood Products Introduction
11.22.4 CBPO Revenue in Blood Banking and Blood Products Business (2020-2025)
11.22.5 CBPO Recent Development
11.23 Hualan Bio
11.23.1 Hualan Bio Company Details
11.23.2 Hualan Bio Business Overview
11.23.3 Hualan Bio Blood Banking and Blood Products Introduction
11.23.4 Hualan Bio Revenue in Blood Banking and Blood Products Business (2020-2025)
11.23.5 Hualan Bio Recent Development
11.24 Tiantan Bio
11.24.1 Tiantan Bio Company Details
11.24.2 Tiantan Bio Business Overview
11.24.3 Tiantan Bio Blood Banking and Blood Products Introduction
11.24.4 Tiantan Bio Revenue in Blood Banking and Blood Products Business (2020-2025)
11.24.5 Tiantan Bio Recent Development
11.25 Shuanglin Bio
11.25.1 Shuanglin Bio Company Details
11.25.2 Shuanglin Bio Business Overview
11.25.3 Shuanglin Bio Blood Banking and Blood Products Introduction
11.25.4 Shuanglin Bio Revenue in Blood Banking and Blood Products Business (2020-2025)
11.25.5 Shuanglin Bio Recent Development
11.26 Boya Bio
11.26.1 Boya Bio Company Details
11.26.2 Boya Bio Business Overview
11.26.3 Boya Bio Blood Banking and Blood Products Introduction
11.26.4 Boya Bio Revenue in Blood Banking and Blood Products Business (2020-2025)
11.26.5 Boya Bio Recent Development
11.27 Yuanda Shuyang
11.27.1 Yuanda Shuyang Company Details
11.27.2 Yuanda Shuyang Business Overview
11.27.3 Yuanda Shuyang Blood Banking and Blood Products Introduction
11.27.4 Yuanda Shuyang Revenue in Blood Banking and Blood Products Business (2020-2025)
11.27.5 Yuanda Shuyang Recent Development
11.28 Weiguang Bio
11.28.1 Weiguang Bio Company Details
11.28.2 Weiguang Bio Business Overview
11.28.3 Weiguang Bio Blood Banking and Blood Products Introduction
11.28.4 Weiguang Bio Revenue in Blood Banking and Blood Products Business (2020-2025)
11.28.5 Weiguang Bio Recent Development
11.29 Nanyue Bio
11.29.1 Nanyue Bio Company Details
11.29.2 Nanyue Bio Business Overview
11.29.3 Nanyue Bio Blood Banking and Blood Products Introduction
11.29.4 Nanyue Bio Revenue in Blood Banking and Blood Products Business (2020-2025)
11.29.5 Nanyue Bio Recent Development
11.30 KM Biologics
11.30.1 KM Biologics Company Details
11.30.2 KM Biologics Business Overview
11.30.3 KM Biologics Blood Banking and Blood Products Introduction
11.30.4 KM Biologics Revenue in Blood Banking and Blood Products Business (2020-2025)
11.30.5 KM Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Blood Banking and Blood Products Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of RBCs
Table 3. Key Players of Plts
Table 4. Key Players of Plasma
Table 5. Key Players of Whole Blood
Table 6. Key Players of Plasma Fractionation Products
Table 7. Global Blood Banking and Blood Products Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Blood Banking and Blood Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Blood Banking and Blood Products Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Blood Banking and Blood Products Market Share by Region (2020-2025)
Table 11. Global Blood Banking and Blood Products Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Blood Banking and Blood Products Market Share by Region (2026-2031)
Table 13. Blood Banking and Blood Products Market Trends
Table 14. Blood Banking and Blood Products Market Drivers
Table 15. Blood Banking and Blood Products Market Challenges
Table 16. Blood Banking and Blood Products Market Restraints
Table 17. Global Blood Banking and Blood Products Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Blood Banking and Blood Products Market Share by Players (2020-2025)
Table 19. Global Top Blood Banking and Blood Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Banking and Blood Products as of 2024)
Table 20. Ranking of Global Top Blood Banking and Blood Products Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Blood Banking and Blood Products Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Blood Banking and Blood Products, Headquarters and Area Served
Table 23. Global Key Players of Blood Banking and Blood Products, Product and Application
Table 24. Global Key Players of Blood Banking and Blood Products, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Blood Banking and Blood Products Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Blood Banking and Blood Products Revenue Market Share by Type (2020-2025)
Table 28. Global Blood Banking and Blood Products Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Blood Banking and Blood Products Revenue Market Share by Type (2026-2031)
Table 30. Global Blood Banking and Blood Products Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Blood Banking and Blood Products Revenue Market Share by Application (2020-2025)
Table 32. Global Blood Banking and Blood Products Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Blood Banking and Blood Products Revenue Market Share by Application (2026-2031)
Table 34. North America Blood Banking and Blood Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Blood Banking and Blood Products Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Blood Banking and Blood Products Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Blood Banking and Blood Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Blood Banking and Blood Products Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Blood Banking and Blood Products Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Blood Banking and Blood Products Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Blood Banking and Blood Products Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Blood Banking and Blood Products Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Blood Banking and Blood Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Blood Banking and Blood Products Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Blood Banking and Blood Products Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Blood Banking and Blood Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Blood Banking and Blood Products Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Blood Banking and Blood Products Market Size by Country (2026-2031) & (US$ Million)
Table 49. America’s Blood Centers Company Details
Table 50. America’s Blood Centers Business Overview
Table 51. America’s Blood Centers Blood Banking and Blood Products Product
Table 52. America’s Blood Centers Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 53. America’s Blood Centers Recent Development
Table 54. Japan Red Cross Society Company Details
Table 55. Japan Red Cross Society Business Overview
Table 56. Japan Red Cross Society Blood Banking and Blood Products Product
Table 57. Japan Red Cross Society Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 58. Japan Red Cross Society Recent Development
Table 59. American Red Cross Company Details
Table 60. American Red Cross Business Overview
Table 61. American Red Cross Blood Banking and Blood Products Product
Table 62. American Red Cross Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 63. American Red Cross Recent Development
Table 64. Australia Red Cross Company Details
Table 65. Australia Red Cross Business Overview
Table 66. Australia Red Cross Blood Banking and Blood Products Product
Table 67. Australia Red Cross Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 68. Australia Red Cross Recent Development
Table 69. Red Cross Society of China Company Details
Table 70. Red Cross Society of China Business Overview
Table 71. Red Cross Society of China Blood Banking and Blood Products Product
Table 72. Red Cross Society of China Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 73. Red Cross Society of China Recent Development
Table 74. NHS Blood and Transplant Company Details
Table 75. NHS Blood and Transplant Business Overview
Table 76. NHS Blood and Transplant Blood Banking and Blood Products Product
Table 77. NHS Blood and Transplant Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 78. NHS Blood and Transplant Recent Development
Table 79. New York Blood Center Company Details
Table 80. New York Blood Center Business Overview
Table 81. New York Blood Center Blood Banking and Blood Products Product
Table 82. New York Blood Center Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 83. New York Blood Center Recent Development
Table 84. Canadian Blood Services Company Details
Table 85. Canadian Blood Services Business Overview
Table 86. Canadian Blood Services Blood Banking and Blood Products Product
Table 87. Canadian Blood Services Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 88. Canadian Blood Services Recent Development
Table 89. Sanquin Blood Supply Foundation Company Details
Table 90. Sanquin Blood Supply Foundation Business Overview
Table 91. Sanquin Blood Supply Foundation Blood Banking and Blood Products Product
Table 92. Sanquin Blood Supply Foundation Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 93. Sanquin Blood Supply Foundation Recent Development
Table 94. Blood Bank of Alaska Company Details
Table 95. Blood Bank of Alaska Business Overview
Table 96. Blood Bank of Alaska Blood Banking and Blood Products Product
Table 97. Blood Bank of Alaska Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 98. Blood Bank of Alaska Recent Development
Table 99. Vitalant Company Details
Table 100. Vitalant Business Overview
Table 101. Vitalant Blood Banking and Blood Products Product
Table 102. Vitalant Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 103. Vitalant Recent Development
Table 104. National Blood Transfusion Council Company Details
Table 105. National Blood Transfusion Council Business Overview
Table 106. National Blood Transfusion Council Blood Banking and Blood Products Product
Table 107. National Blood Transfusion Council Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 108. National Blood Transfusion Council Recent Development
Table 109. Takeda Company Details
Table 110. Takeda Business Overview
Table 111. Takeda Blood Banking and Blood Products Product
Table 112. Takeda Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 113. Takeda Recent Development
Table 114. CSL Company Details
Table 115. CSL Business Overview
Table 116. CSL Blood Banking and Blood Products Product
Table 117. CSL Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 118. CSL Recent Development
Table 119. Grifols Company Details
Table 120. Grifols Business Overview
Table 121. Grifols Blood Banking and Blood Products Product
Table 122. Grifols Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 123. Grifols Recent Development
Table 124. Octapharma Company Details
Table 125. Octapharma Business Overview
Table 126. Octapharma Blood Banking and Blood Products Product
Table 127. Octapharma Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 128. Octapharma Recent Development
Table 129. Kedrion Company Details
Table 130. Kedrion Business Overview
Table 131. Kedrion Blood Banking and Blood Products Product
Table 132. Kedrion Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 133. Kedrion Recent Development
Table 134. LFB Group Company Details
Table 135. LFB Group Business Overview
Table 136. LFB Group Blood Banking and Blood Products Product
Table 137. LFB Group Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 138. LFB Group Recent Development
Table 139. Biotest Company Details
Table 140. Biotest Business Overview
Table 141. Biotest Blood Banking and Blood Products Product
Table 142. Biotest Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 143. Biotest Recent Development
Table 144. BPL Company Details
Table 145. BPL Business Overview
Table 146. BPL Blood Banking and Blood Products Product
Table 147. BPL Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 148. BPL Recent Development
Table 149. RAAS Company Details
Table 150. RAAS Business Overview
Table 151. RAAS Blood Banking and Blood Products Product
Table 152. RAAS Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 153. RAAS Recent Development
Table 154. CBPO Company Details
Table 155. CBPO Business Overview
Table 156. CBPO Blood Banking and Blood Products Product
Table 157. CBPO Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 158. CBPO Recent Development
Table 159. Hualan Bio Company Details
Table 160. Hualan Bio Business Overview
Table 161. Hualan Bio Blood Banking and Blood Products Product
Table 162. Hualan Bio Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 163. Hualan Bio Recent Development
Table 164. Tiantan Bio Company Details
Table 165. Tiantan Bio Business Overview
Table 166. Tiantan Bio Blood Banking and Blood Products Product
Table 167. Tiantan Bio Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 168. Tiantan Bio Recent Development
Table 169. Shuanglin Bio Company Details
Table 170. Shuanglin Bio Business Overview
Table 171. Shuanglin Bio Blood Banking and Blood Products Product
Table 172. Shuanglin Bio Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 173. Shuanglin Bio Recent Development
Table 174. Boya Bio Company Details
Table 175. Boya Bio Business Overview
Table 176. Boya Bio Blood Banking and Blood Products Product
Table 177. Boya Bio Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 178. Boya Bio Recent Development
Table 179. Yuanda Shuyang Company Details
Table 180. Yuanda Shuyang Business Overview
Table 181. Yuanda Shuyang Blood Banking and Blood Products Product
Table 182. Yuanda Shuyang Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 183. Yuanda Shuyang Recent Development
Table 184. Weiguang Bio Company Details
Table 185. Weiguang Bio Business Overview
Table 186. Weiguang Bio Blood Banking and Blood Products Product
Table 187. Weiguang Bio Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 188. Weiguang Bio Recent Development
Table 189. Nanyue Bio Company Details
Table 190. Nanyue Bio Business Overview
Table 191. Nanyue Bio Blood Banking and Blood Products Product
Table 192. Nanyue Bio Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 193. Nanyue Bio Recent Development
Table 194. KM Biologics Company Details
Table 195. KM Biologics Business Overview
Table 196. KM Biologics Blood Banking and Blood Products Product
Table 197. KM Biologics Revenue in Blood Banking and Blood Products Business (2020-2025) & (US$ Million)
Table 198. KM Biologics Recent Development
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
Table 202. Authors List of This Report


List of Figures
Figure 1. Blood Banking and Blood Products Picture
Figure 2. Global Blood Banking and Blood Products Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Blood Banking and Blood Products Market Share by Type: 2024 VS 2031
Figure 4. RBCs Features
Figure 5. Plts Features
Figure 6. Plasma Features
Figure 7. Whole Blood Features
Figure 8. Plasma Fractionation Products Features
Figure 9. Global Blood Banking and Blood Products Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Blood Banking and Blood Products Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Retail Pharmacy Case Studies
Figure 14. Others Case Studies
Figure 15. Blood Banking and Blood Products Report Years Considered
Figure 16. Global Blood Banking and Blood Products Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Blood Banking and Blood Products Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Blood Banking and Blood Products Market Share by Region: 2024 VS 2031
Figure 19. Global Blood Banking and Blood Products Market Share by Players in 2024
Figure 20. Global Top Blood Banking and Blood Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Banking and Blood Products as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Blood Banking and Blood Products Revenue in 2024
Figure 22. North America Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Blood Banking and Blood Products Market Share by Country (2020-2031)
Figure 24. United States Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Blood Banking and Blood Products Market Share by Country (2020-2031)
Figure 28. Germany Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Blood Banking and Blood Products Market Share by Region (2020-2031)
Figure 36. China Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Blood Banking and Blood Products Market Share by Country (2020-2031)
Figure 44. Mexico Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Blood Banking and Blood Products Market Share by Country (2020-2031)
Figure 48. Turkey Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Blood Banking and Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. America’s Blood Centers Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 52. Japan Red Cross Society Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 53. American Red Cross Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 54. Australia Red Cross Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 55. Red Cross Society of China Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 56. NHS Blood and Transplant Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 57. New York Blood Center Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 58. Canadian Blood Services Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 59. Sanquin Blood Supply Foundation Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 60. Blood Bank of Alaska Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 61. Vitalant Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 62. National Blood Transfusion Council Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 63. Takeda Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 64. CSL Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 65. Grifols Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 66. Octapharma Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 67. Kedrion Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 68. LFB Group Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 69. Biotest Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 70. BPL Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 71. RAAS Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 72. CBPO Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 73. Hualan Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 74. Tiantan Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 75. Shuanglin Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 76. Boya Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 77. Yuanda Shuyang Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 78. Weiguang Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 79. Nanyue Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 80. KM Biologics Revenue Growth Rate in Blood Banking and Blood Products Business (2020-2025)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock